Also trades as: 4527.T (JPX) · $vol 20M
RPHCF OTC
Rohto Pharmaceutical Co.,Ltd.
1W: +0.0%
1M: -1.1%
3M: -1.1%
YTD: -9.0%
1Y: +inf%
3Y: -29.3%
5Y: -74.5%
$15.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$48.1B
+30.3% ▲
5Y CAGR: +19.2%
Capital Expenditures
$11.6B
-9.5% ▼
5Y CAGR: +162.2%
Free Cash Flow
$36.5B
+38.6% ▲
5Y CAGR: +234.0%
Dividends Paid
$9.3B
-31.8% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
$9.4B
+170.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $174M | $199M | $41.5B | $42.3B | $34.5B |
| Depreciation & Amort. | $63M | $59M | $8.7B | $13.1B | $17.5B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $1M | -$44M | -$8.9B | -$4.2B | -$5.7B |
| Other Non-Cash Items | $27.0B | $30.7B | -$7.1B | -$14.4B | $1.9B |
| Operating Cash Flow | $27.2B | $30.9B | $34.2B | $36.9B | $48.1B |
| — Investing Activities — | |||||
| Capital Expenditures | -$93M | -$75M | -$8.9B | -$9.1B | -$26.4B |
| Acquisitions (Net) | -$10M | $820K | $0 | -$74.5B | $26M |
| Investment Purchases | -$46M | -$45M | -$9.1B | -$9.5B | -$7.3B |
| Investment Sales | $16M | $20M | $1.7B | $6.0B | $4.0B |
| Other Investing | -$16.3B | -$13.1B | -$29M | -$2.0B | -$275M |
| Investing Cash Flow | -$16.4B | -$13.2B | -$16.3B | -$89.2B | -$30.0B |
| — Financing Activities — | |||||
| Net Debt Issuance | $7.6B | -$9.9B | -$1.2B | $31.9B | -$2.6B |
| Stock Repurchased | $0 | $0 | $0 | -$5.0B | $0 |
| Dividends Paid | -$3.4B | -$4.7B | -$5.5B | -$7.1B | -$9.3B |
| Other Financing | -$698M | -$1.6B | -$7.1B | $15.5B | -$3M |
| Financing Cash Flow | $3.5B | -$16.2B | -$13.8B | $35.3B | -$11.9B |
| Net Change in Cash | $18.7B | $6.8B | $8.9B | -$13.3B | $9.4B |
| Cash End of Period | $582M | $585M | $86.6B | $73.2B | $87.4B |
| Free Cash Flow | $131M | $158M | $25.3B | $26.4B | $36.5B |